Clinical Trials on Bladder Urothelial Cancer in Canada
Total 3843 results
-
National Cancer Institute (NCI)WithdrawnUrothelial Carcinoma | Renal Pelvis and Ureter Urothelial Carcinoma | Bladder Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage IVA Bladder Cancer AJCC v8 | Bladder Urothelial Carcinoma | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8Canada
-
University Health Network, TorontoBladder Cancer CanadaRecruitingBladder Cancer | Bladder Urothelial CarcinomaCanada
-
University Health Network, TorontoCanadian Urological Association; Canadian Urologic Oncology Group; Bladder Cancer...TerminatedBladder Cancer | Bladder Urothelial CarcinomaCanada
-
AHS Cancer Control AlbertaPfizerCompletedBladder Cancer | Urothelial Cancer | AdultCanada
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Bladder Urothelial Carcinoma | Advanced Ureter Urothelial Carcinoma | Metastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage III... and other conditionsUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Urothelial Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Locally Advanced Urothelial CarcinomaUnited States, Canada
-
Bernie EiglLady Davis Institute; Vancouver Prostate Centre; Bladder Cancer CanadaRecruitingMetastatic Urothelial Carcinoma | Metastatic Bladder CancerCanada
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingAtezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder CancerRecurrent Bladder Urothelial Carcinoma | Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage I Bladder Urothelial Carcinoma AJCC v6 and v7United States, Canada
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedUpper Tract Urothelial Carcinomas | Urothelial Bladder CancerUnited States, France, Canada, Spain, Italy, Belgium, Germany, Netherlands, United Kingdom, Bulgaria, Greece
-
National Cancer Institute (NCI)CompletedMetastatic Urethral Carcinoma | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage III Ureter Cancer AJCC v7 | Stage III Urethral Cancer AJCC v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Stage IV Ureter Cancer AJCC v7 | Stage IV Urethral Cancer AJCC v7 | Ureter Urothelial Carcinoma and other conditionsUnited States, Canada
-
PfizerTerminatedUrinary Bladder Neoplasms | Bladder Cancer | Urothelial Carcinoma | Bladder TumorsCanada
-
Ontario Clinical Oncology Group (OCOG)Cancer Care OntarioActive, not recruitingMuscle-invasive Bladder CancerCanada
-
Sesen Bio, Inc.CompletedUrinary Bladder Cancer | Bladder Cancer | Bladder Neoplasms | Bladder TumorsUnited States, Canada
-
National Cancer Institute (NCI)Radiation Therapy Oncology GroupCompletedBladder Urothelial Carcinoma | Stage I Bladder Cancer AJCC v6 and v7 | Stage II Bladder Cancer AJCC v6 and v7 | Stage III Bladder Cancer AJCC v6 and v7United States, Canada
-
University Health Network, TorontoAmgenCompletedStudy Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone MetastasesKidney Cancer | Bladder Cancer | Urothelial Carcinoma | Ureter CancerCanada
-
London Health Sciences CentrePacific Edge LimitedUnknown
-
Pierre Fabre MedicamentBristol-Myers SquibbCompletedBladder Cancer | Bladder Neoplasms | Transitional Cell Carcinoma of the Urothelial TractCanada
-
Astellas Pharma Global Development, Inc.Seagen Inc.CompletedMetastatic Urothelial CancerUnited States, Canada
-
McGill University Health Centre/Research Institute...CompletedUrinary Bladder Cancer | Bladder Cancer | Entire Ileal ConduitCanada
-
Canadian Cancer Trials GroupCelgene; Australian and New Zealand Urogenital and Prostate Cancer Trials GroupCompletedUrothelial CancerCanada, Australia
-
AdaptimmuneCompletedMelanoma | Head and Neck Cancer | Urothelial Carcinoma | Bladder Urothelial CarcinomaUnited States, Canada, Spain
-
Mansoura UniversityRecruitingNon-Muscle Invasive Bladder CancerEgypt
-
Theralase Inc.University Health Network, Toronto; WCCT Global; Medelis Inc.CompletedNon-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCGCanada
-
Western University, CanadaCompletedBladder Cancer | Hematuria | Bladder DiseaseCanada
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional...Canada
-
University of British ColumbiaRecruitingTransitional Cell Cancer of the Renal Pelvis and Ureter | Urothelial Carcinoma of the Renal Pelvis and UreterCanada
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.RecruitingUrothelial CancerUnited States, Argentina, Australia, Belgium, Canada, China, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Singapore, Spain, Switzerland, Taiwan, Thailand and more
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CancerKorea, Republic of, United States, Italy, Spain, Japan, United Kingdom, Belgium, Israel, China, Austria, France, Canada, Taiwan, Turkey, Germany, Russian Federation, Bulgaria, Poland, Greece, Brazil, Netherlands, Australia, Argentina, Mexic... and more
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR)RecruitingNon-Muscle Invasive Bladder CancerCanada
-
Ottawa Hospital Research InstituteTerminated
-
London Health Sciences CentreUnknown
-
AstraZenecaActive, not recruitingUrothelial CancerUnited States, Belgium, Denmark, Germany, Italy, Spain, Canada, Poland, Taiwan, France, Korea, Republic of, Netherlands, United Kingdom, Brazil, Japan, Mexico, Russian Federation, Turkey, China, Austria, Australia, Israel, Portugal, G...
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingUrothelial CancerRussian Federation, United States, Brazil, Spain, Chile, Korea, Republic of, Argentina, Australia, Canada, China, Czechia, Denmark, Finland, France, Germany, Greece, Israel, Italy, Japan, Mexico, Netherlands, Norway, Peru, Poland, Romania, Swed... and more
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompleted
-
Lawson Health Research InstituteTerminated
-
McGill University Health Centre/Research Institute...Unknown
-
University of British ColumbiaWithdrawnBladder Cancer | High-Risk Cancer | Durvalumab | Non-muscle Invasive | TremelimumabCanada
-
Lawson Health Research InstituteCompleted
-
Vancouver Coastal HealthNCIC Clinical Trials Group; Vancouver General Hospital FoundationUnknown
-
AstraZenecaActive, not recruitingMetastatic Urothelial Cancer | Unresectable Locally Advanced Urothelial CancerUnited States, Italy, Spain, Canada, Hungary, Poland, Argentina, Thailand, Vietnam, Turkey, Korea, Republic of, Brazil, Czechia, India, Japan, Philippines, Russian Federation, China, Taiwan, Israel, Australia, Bulgaria
-
Vancouver Coastal HealthUniversity of British Columbia; Vancouver Prostate CentreUnknownPostoperative Pain | Bladder CancerCanada
-
CHU de Quebec-Universite LavalCancer Research SocietyWithdrawnMetastatic Urothelial CarcinomaCanada
-
Ottawa Hospital Research InstituteAstraZeneca; Hamilton Health Sciences Corporation; London Health Sciences Centre and other collaboratorsRecruitingBladder CancerCanada
-
Astellas Pharma Global Development, Inc.Seagen Inc.CompletedMetastatic Urothelial Cancer and Other Malignant Solid TumorsUnited States, Canada
-
Novartis PharmaceuticalsCompletedUrothelial CancerUnited States, Spain, Taiwan, Germany, Canada, United Kingdom, Italy, Austria
-
G1 Therapeutics, Inc.TerminatedBladder Cancer | Urothelial Carcinoma | Chemotherapy-induced Neutropenia | Myelosuppression Adult | Metastatic Bladder CancerHungary, Spain, United States, France, Georgia
-
Astellas Pharma Global Development, Inc.Seagen Inc.Active, not recruitingBladder Cancer | Urothelial Cancer | Ureteral CancerUnited States, Japan, Korea, Republic of, Taiwan, Argentina, Australia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, Portugal, Russian Federation, Spain, Switzerland, United Kingdom
-
University of AlbertaCross Cancer Institute; Northern Alberta Urology CentreRecruiting
-
Gilead SciencesEverest MedicinesActive, not recruitingLocally Advanced or Metastatic Unresectable Urothelial CancerUnited States, Belgium, France, Spain, United Kingdom, Korea, Republic of, Czechia, Germany, Israel, China, Italy, Australia, Hong Kong, Taiwan, Portugal, Singapore, Croatia, Greece, Turkey, Sweden, Switzerland, Canada, Austria, Bulgaria and more